side

The Difference in Guanfacine Formulations for ADHD

By: Katharine Cimmino, Editor-in-Chief - Attention-deficit/hyperactivity disorder (ADHD) is the most common pediatric psychiatric disorder, and it affects the education,…

12 years ago

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

Off-Label Antidepressant Use in Pediatric Patients with Autism

By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences -- Psychotropic medications are…

12 years ago

Accountable Care Organizations

By: Stephanie Chiu and Elissa Tam, PharmD Candidates c/o 2015 -- According to the Dartmouth Atlas project, health care spending…

12 years ago

FDA-Approved Afrezza: An Inhaled Alternative to Injectable Insulin?

By: Elissa Tam, PharmD Candidate c/o 2015 - Patients with Type 1 or Type 2 diabetes who cannot control their…

12 years ago

HIV Pre-Exposure Prophylaxis

By: Elissa Tam PharmD Candidate c/o 2015 - HIV/AIDS continues to be a persistent problem in the United States and…

12 years ago

Reservoir of Migraine Therapies Includes Analgesics, AEDs, and now Monoclonal Antibodies

By Davidta Brown, Senior Staff Editor - The pain, nausea, and light or sound sensitivity that comprise a migraine attack…

12 years ago

Drug Shortages: Effects & Costs in the United States Healthcare System

By: Valentina DiGangi,PharmD Candidate c/o 2017, Brandon Hu, PharmD Candidate c/o 2018, Sang Hyo Kim, Staff Editor, Samantha Lau, PharmD…

12 years ago

Migraine Relief at the Push of a Button

By: Davidta Brown, Senior Staff Editor - A new therapeutic device has seemingly leapt from the pages of a science…

12 years ago

Tailored Tablets

By: Azia Tariq, Staff Editor - Truly personalized medication is the goal of researchers in the pharmaceutical and biotechnological industries.…

12 years ago

The Importance of the Measles Vaccine: Should We Be Vaccinated?

By: Sherin Pathickal, PharmD Candidate c/o 2016 - The mandatory receipt of vaccinations as a preventive public health measure has…

12 years ago

I Have a Problem

By: Sang Hyub Kim, DPM Candidate c/o 2018, New York College of Podiatric Medicine - I was diagnosed with ulcerative…

12 years ago

Asking Questions

By: Bharat Kirthivasan, Co-Copy Editor (Content-focused) - It’s graduation season and some students are moving from academics to professional life.…

12 years ago

FDA Approves Drug Elosulfase Alfa (Vimizim™) for Mucopolysaccharidosis (MPS IVA)

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…

12 years ago

Possible New Prostate Cancer Screening

By: Fatema Elias, Senior Staff Editor - Prostate cancer occurs when abnormal cells form in the tissues of the prostate…

12 years ago

The Use of Topical Opioid Treatment for Pressure Ulcer Wounds

By: Katharine Cimmino, Editor-in-Chief - Pressure ulcers can be a painful condition decreasing the quality of life of patients and…

12 years ago

Riociguat (Adempas®) New Drug for Pulmonary Hypertension

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

Dietary Supplements and Their Potential Dangers

By: Fatema Elias, Staff Writer - With the New Year and everyone committing to their New Year resolutions, more and…

12 years ago

The Importance of Organ Donation: Perspectives and the Lives Affected

By: James Schurr, PharmD Candidate c/o 2014 and Jennifer Miao, PharmD Candidate c/o 2014 With very special thanks to Jessica…

12 years ago

Psychiatric Prescriptions in the Fight Against Juvenile Diabetes

By: Davidta Brown, Senior Staff Editor - In August 2013, the results of a yearlong safety study were published in…

12 years ago

Long Term PPI Use Heightens Concern of Associated Health Consequences

By: Tamara Yunusova, Senior Staff Editor - Proton Pump Inhibitors (PPIs) are acid-reducing agents that have multiple uses in the…

12 years ago

Low Literacy and Medication Management?

By: Jenny Park, Pharm. D. Candidate c/o 2015 - As the Affordable Care Act brings health care to many people…

12 years ago

The Increasing Roles of Pharmacists in Transplant Outcomes

By: Jenny Park, PharmD Candidate c/o 2015 - Medication adherence is a big part of a patient’s success in managing…

12 years ago

Pharmacy Across the Border: An Interview with Sherif Guorgui, VP of Pharmacy at the Ontario Pharmacists Association

By: Sang Hyo Kim, Staff Editor - For the brand new year, we present an interview with Sherif Guorgui, the…

12 years ago

New Hepatitis C Drug Receives FDA Approval

By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…

12 years ago

Direct Association of HIV and Early Kidney Damage in Women

By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC - Human immunodeficiency virus (HIV)…

12 years ago

Newly Approved: Macitentan (Opsumit®)

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy - The FDA approved macitentan (Opsumit®) on October…

13 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Hospital Drug Shortages

By: Hamid Razaki, PharmD - Drug shortages seen across pharmacies in the United States continue to be an issue in…

13 years ago

Still a Long Road Ahead for New Hepatitis C Treatment

By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…

13 years ago

Zecuity(TM): Novel Treatment Option for Migraines

By: Arya Mathew, PharmD Candidate c/o 2014 -  About twelve percent of the U.S. population suffers from migraines, affecting adult…

13 years ago

Does Moxifloxacin Increase the Risk of Dysglycemia?

By: Nathan Trustman, PharmD Candidate c/o 2014, AMSCOP at LIU - The antibiotic class known as the fluoroquinolones is widely…

13 years ago

New Treatment for a Deficiency in Iron-Supplement Therapies

By: Davidta Brown, Staff Editor - For the estimated 7.5 million individuals in the United States living with iron deficiency…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

Meet the Dean: Interview with Dean DiGate

By: Katharine Cimmino, Editor-in-Chief and Erica Dimitropoulos, Senior Staff Editor -       Just last month, St. John’s University…

13 years ago

Olmesartan Medoxomil Label Revision

By: David Ong, PharmD Candidate c/o 2014 - Manipulating the renin-angiotensin system is one of the many ways drugs are…

13 years ago

Drugs and Diseases: The Survival Manual

By: Beatrisa Popovitz, Staff Editor -  You may have heard the countless horror stories passed on by upperclassman of how…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Can a Pharmacist Prevent the Next Pileup?

By: Moisey Rafailov, PharmD Candidate c/o 2015 - It was early in the morning on New York’s Route 684 when…

13 years ago

Purple Glove Syndrome

By: Sharon Janak, PharmD Candidate c/o 2013 - How can we distinguish between vascular injury and Purple Glove Syndrome (an…

13 years ago

Pilltalk: Innovation to Simplify Patient Counseling

By: Mitesh Patel, PharmD Candidate 2014 - $1.2 trillion- This is what the United States spends on healthcare. At 17%…

13 years ago

AUVI-Q™: The Newest Epinephrine Device to Hit the Market

By: Diana Gritsenko, Pharm D. Candidate c/o 2015 - Most of us who work in a community pharmacy setting will…

13 years ago

Plan B® Pill Now Available Without Prescription to Women 15 Years of Age and Older

By: Bansri Patel - As of May 1st 2013, Plan B®, the brand name emergency contraception pill will now be…

13 years ago

The Honors Program Spotlight

By: Steve Soman - The St. John’s University Honors Program features small classes, faculty mentoring, and an impressive number of…

13 years ago

FDA Approves New Drug ‘Tofacitinib’ for Rheumatoid Arthritis

By: Erica Dimitropoulos, Senior Staff Editor - Rheumatoid arthritis is a painful and often debilitating autoimmune disease characterized by symmetric…

13 years ago

Pharmaceutical Industry: More than One Way In

By: David Ong, Pharm.D. Candidate c/o 2014 - There are many research opportunities available for pharmacists after graduation. However, most…

13 years ago

New FDA Approval: Fycompa® to Treat Seizures

By: Bhavini Shah, PharmD Candidate c/o 2013  - Fycompa® (perampanel) has received the U.S. Food and Drug Administration (FDA) approval…

13 years ago

FDA Approves New Indication for Botox (OnabotulinumtoxinA) for Urinary Incontinence

By: Bethsy Jacob, PharmD Candidate 2014 - On January 18, 2013, the U.S. Food and Drug Administration (FDA) announced a…

13 years ago

A Look at Primary Medication NonAdherence and How it can be Overcome

By:  Erica Dimitropoulos, Assistant Student Editor - Although clinical trials can affirm the efficacy and advantages of all marketed medications,…

13 years ago